Presentation is loading. Please wait.

Presentation is loading. Please wait.

Integrative Therapy Use as a Comfort Measure with BMT Patients

Published byThijs Verstraeten Modified over 5 years ago

Similar presentations

Presentation on theme: "Integrative Therapy Use as a Comfort Measure with BMT Patients"— Presentation transcript:

1 Integrative Therapy Use as a Comfort Measure with BMT Patients
Karen Gastecki, RN BSN, Joanie Aasen, RN, MSN, Colleen Thornton, PA-C, Sarah Rounds, BA  Biology of Blood and Marrow Transplantation  Volume 22, Issue 3, Pages S277-S278 (March 2016) DOI: /j.bbmt Copyright © Terms and Conditions

2 Picture 1: Comfort Menu. Biology of Blood and Marrow Transplantation  , S277-S278DOI: ( /j.bbmt ) Copyright © Terms and Conditions

3 Picture 2: Care plan individualization in EHR.
Biology of Blood and Marrow Transplantation  , S277-S278DOI: ( /j.bbmt ) Copyright © Terms and Conditions

4 Picture 3: CAPA documentation.
Biology of Blood and Marrow Transplantation  , S277-S278DOI: ( /j.bbmt ) Copyright © Terms and Conditions

5 Picture 4: HCAPs responses.
Biology of Blood and Marrow Transplantation  , S277-S278DOI: ( /j.bbmt ) Copyright © Terms and Conditions

Download ppt "Integrative Therapy Use as a Comfort Measure with BMT Patients"

Similar presentations

Identification of CD137+ IFN-g- CD4+ Alloreactive T Cells Post Myeloablative Double Cord Blood Transplant: A Synergistic Role in the Graft Verus Graft.

Identification of CD137+ IFN-g- CD4+ Alloreactive T Cells Post Myeloablative Double Cord Blood Transplant: A Synergistic Role in the Graft Verus Graft.
Stephanie J. Lee, Loretta A. Williams 

Stephanie J. Lee, Loretta A. Williams 
Biology of Blood and Marrow Transplantation

Biology of Blood and Marrow Transplantation
Michael A. Pulsipher, Christina Peters, Ching-Hon Pui 

Michael A. Pulsipher, Christina Peters, Ching-Hon Pui 
Improvement of Disease Status Determination and Documentation Pre- and Post- Transplant  Michelle Bycko, Crystal Gazaway, Jennifer Holter Chakrabarty,

Improvement of Disease Status Determination and Documentation Pre- and Post- Transplant  Michelle Bycko, Crystal Gazaway, Jennifer Holter Chakrabarty,
How to Treat MDS without Stem Cell Transplantation

How to Treat MDS without Stem Cell Transplantation
Microsoft Access®: A Viable Blood and Marrow Transplant (BMT) Database Solution  Lindsay Dozeman, Alison Amendola, MHA, Connie Grobe, Lisa Cantwell, MHA,

Microsoft Access®: A Viable Blood and Marrow Transplant (BMT) Database Solution  Lindsay Dozeman, Alison Amendola, MHA, Connie Grobe, Lisa Cantwell, MHA,
Hematopoietic Cell Transplantation Provides Durable Disease Control in Patients with Double-Hit Lymphoma  Taewoong Choi, Murali K. Kodali, Wen-Kai Weng 

Hematopoietic Cell Transplantation Provides Durable Disease Control in Patients with Double-Hit Lymphoma  Taewoong Choi, Murali K. Kodali, Wen-Kai Weng 
Improvement in Hematopoiesis with Treatment of Iron Overload Following Allogeneic Transplants  Akash Mukherjee, MD, Dhaval Shah, MD, Gloria Obi, PhD,

Improvement in Hematopoiesis with Treatment of Iron Overload Following Allogeneic Transplants  Akash Mukherjee, MD, Dhaval Shah, MD, Gloria Obi, PhD,
Using A3 Methodology to Identify the Root Cause of a Chemotherapy Error in a Hematopoietic Stem Cell Transplant Patient  Kathlene DeGregory, PharmD, BCOP,

Using A3 Methodology to Identify the Root Cause of a Chemotherapy Error in a Hematopoietic Stem Cell Transplant Patient  Kathlene DeGregory, PharmD, BCOP,
Infusion of Ex Vivo Expanded Cord Blood Progenitor Cells Is Associated with Reduced Hospital Days and Utilization of Opiate Infusion and Total Parenteral.

Infusion of Ex Vivo Expanded Cord Blood Progenitor Cells Is Associated with Reduced Hospital Days and Utilization of Opiate Infusion and Total Parenteral.
Continuous Intravenous Immunoglobulin and Platelet Infusion in Allogeneic Stem Cell Transplant Patients with Allo-Immune Thrombocytopenia  Katerina Ancevski,

Continuous Intravenous Immunoglobulin and Platelet Infusion in Allogeneic Stem Cell Transplant Patients with Allo-Immune Thrombocytopenia  Katerina Ancevski,
Richard Gopez Ancheta, MD, Carol Burian, CCRP, William E

Richard Gopez Ancheta, MD, Carol Burian, CCRP, William E
Predictive Value of Pre-Transplant PET/CT Scan before Autologous Stem Cell Transplant in Mantle Cell Lymphoma  Brian Hess, MD, Kathryn Trinkaus, Ph.D.,

Predictive Value of Pre-Transplant PET/CT Scan before Autologous Stem Cell Transplant in Mantle Cell Lymphoma  Brian Hess, MD, Kathryn Trinkaus, Ph.D.,
Impact of Pre-Transplant Minimal Residual Disease in Patients with AML Undergoing Myeloablative Cord Blood Transplantation  Filippo Milano, MD, PhD, Brent.

Impact of Pre-Transplant Minimal Residual Disease in Patients with AML Undergoing Myeloablative Cord Blood Transplantation  Filippo Milano, MD, PhD, Brent.
Development of Pre-Transplant Facesheet for Improved Accuracy of Data Collection through Direct Clinical Oversight  Madhu Ragupathi, Jaskiran Kaur, Mostafizur.

Development of Pre-Transplant Facesheet for Improved Accuracy of Data Collection through Direct Clinical Oversight  Madhu Ragupathi, Jaskiran Kaur, Mostafizur.
Optimizing Data Collection for Long-Term Follow-Up after Hematopoietic Stem Cell Transplant  Jaskiran Kaur, Madhu Ragupathi, Alysa Pleiner, Luda Kushner,

Optimizing Data Collection for Long-Term Follow-Up after Hematopoietic Stem Cell Transplant  Jaskiran Kaur, Madhu Ragupathi, Alysa Pleiner, Luda Kushner,
Sabina Kersting, Leo F. Verdonck 

Sabina Kersting, Leo F. Verdonck 
Geoffrey Barkley, LCSW, PhD, Julie Perry, M.Div, Chaplaincy 

Geoffrey Barkley, LCSW, PhD, Julie Perry, M.Div, Chaplaincy 
Let Them Eat! Comparing a Neutropenic Diet to a Food Safety Based Diet in Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)  Cynthia.

Let Them Eat! Comparing a Neutropenic Diet to a Food Safety Based Diet in Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)  Cynthia.

Similar presentations

Ads by Google